US-listed companies
GENTEX CORP

GENTEX CORPGNTX

Market cap

$6.8B

P/E ratio

Income statement Balance sheet Cash flow

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Net income	165	169	223	289	318	348	407	438	425	348	361	319	428
Depreciation and amortization	43	50	63	77	81	89	100	102	105	105	99	97	93
Gain on disposal of assets	-	419,382	54,520	44,410	10,900	146,261	188,150	577,200	155,150	311,510	488,750	70,736	-
Gain on disposal of assets	-	-	-	-	-	-	-	-	-	-	-	-	355,544
Loss on disposal of assets	-	-952,190	2	640,918	455,950	1	299,174	108,927	588,941	162,553	230,933	28,424	443,373
Gain on sale of investments and equity method investment income	-	-	-	-	-	-	-	-	660,643	3	1	392,040	5
Loss on Sale of Investments	9	1	882,918	1	3	4	375,388	532,494	176,360	1	307,490	2	11
Deferred income taxes	14	843,484	-7,726,800	15	13	22	-14,996,179	-4,414,739	-3,358,537	-15,419,722	-41,694,751	-17,777,777	-17,735,110
Share-Based Payment Arrangement, Noncash Expense	14	16	17	21	21	19	18	18	22	31	27	30	39
Accounts receivable	15	-810,022	22	25	28	16	20	-17,583,989	22	49	-35,135,429	27	45
Inventories	88	-28,823,046	-39,856,102	22	33	15	27	9	24	-22,725,798	90	88	-2,127,242
Prepaid expenses and other	7	-14,868,742	2	22	10	-4,399,366	-16,183,673	11	4	-10,493,993	20	29	4
Accounts payable	25	-22,270,571	13	15	-5,103,209	14	10	3	5	-12,854,038	7	37	41
Accrued liabilities	2	8	14	-708,190	3	11	13	220,856	3	28	-14,322,863	15	-5,735,441
Net cash flows from operating activities	142	258	317	327	352	471	501	552	506	464	362	338	537
Sales proceeds	-	-	-	-	-	-	-	55	57	24	56	37	59
Maturities and calls	104	76	98	-	-	6	23	182	125	143	28	4	17
Purchases	-	-	-	-	-	-	-	332	153	74	113	30	98
Sales proceeds	-	-	-	-	-	-	-	55	57	24	56	37	59
Maturities and calls	104	76	98	-	-	6	23	182	125	143	28	4	17
Purchases	-	-	-	-	-	-	-	332	153	74	113	30	98
Purchase of technology investments	-	-	-	-	-	-	-	-	-	-	-	34	71
Plant and equipment additions	120	117	55	73	98	121	104	86	85	52	69	146	184
Proceeds from sale of plant and equipment	179,212	1	386,399	223,833	43,544	665,191	249,757	738,093	2	383,429	3	313,917	292,723
Acquisition of businesses, net of cash acquired	-	-	698	-	-	-	-	-	-	11	12	-	19
Increase in other assets	-698,357	18	573,560	2	3	7	-2,646,029	6	3	4	6	4	4
Net cash used for investing activities	-103,526,990	-132,074,244	-633,256,619	-79,713,483	-89,737,661	-251,446,108	-77,712,570	-185,821,194	-56,711,082	26	-113,106,955	-172,738,508	-299,416,320
Proceeds from Issuance of Long-Term Debt	-	-	-	-	-	-	-	-	-	75	-	-	-
Proceeds from Issuance of Common Stock	33	12	38	60	30	81	48	67	78	42	30	17	29
Repayment of borrowings on Credit Agreement	-	-	2	8	33	48	108	78	-	75	-	-	-
Cash dividends paid	67	73	79	88	97	101	109	117	116	117	115	113	112
Proceeds from Issuance of Common Stock	33	12	38	60	30	81	48	67	78	42	30	17	29
Repurchases of common stock	-	34	-	30	111	163	231	592	331	288	325	113	147
Cash dividends paid	67	73	79	88	97	101	109	117	116	117	115	113	112
Net cash used for financing activities	-28,504,674	-94,079,920	236	-59,671,546	-207,713,041	-225,099,138	-400,032,789	-719,306,670	-369,959,438	-363,858,794	-410,119,973	-209,019,053	-230,152,891
Repurchases of common stock	-	34	-	30	111	163	231	592	331	288	325	113	147
Net cash used for financing activities	-28,504,674	-94,079,920	236	-59,671,546	-207,713,041	-225,099,138	-400,032,789	-719,306,670	-369,959,438	-363,858,794	-410,119,973	-209,019,053	-230,152,891
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	-	-	-	-	-	-	-	-	79	127	-161,059,366	-43,557,032	8
Capital Expenditures Incurred but Not yet Paid	-	-	-	-	-	-	-	-	-	-	-	-	7